Recovery in surgery volume buoys Encision sales

BOULDER — Encision Inc. (PK: ECIA) saw a rebound in sales in the first quarter of 2021 as the medical industry slowly returns to performing surgeries that were halted by the pandemic.

The Boulder developer of medical equipment that minimizes electric burns on patients during surgery reported revenues of $2.15 million and a gain of 1 cent per share, compared with revenues of $1.78 million and a net loss of 1 cent per share in the same period last year.

CEO Gregory Trudel said the increase in sales was primarily due to the return of some surgery options across the country earlier…